Matches in SemOpenAlex for { <https://semopenalex.org/work/W3166384713> ?p ?o ?g. }
- W3166384713 endingPage "6270" @default.
- W3166384713 startingPage "6270" @default.
- W3166384713 abstract "The accumulation of uremic toxins (UTs) is a prototypical manifestation of uremic milieu that follows renal function decline (chronic kidney disease, CKD). Frailty as a potential outcome-relevant indicator is also prevalent in CKD. The intertwined relationship between uremic toxins, including small/large solutes (phosphate, asymmetric dimethylarginine) and protein-bound ones like indoxyl sulfate (IS) and p-cresyl sulfate (pCS), and frailty pathogenesis has been documented recently. Uremic toxins were shown in vitro and in vivo to induce noxious effects on many organ systems and likely influenced frailty development through their effects on multiple preceding events and companions of frailty, such as sarcopenia/muscle wasting, cognitive impairment/cognitive frailty, osteoporosis/osteodystrophy, vascular calcification, and cardiopulmonary deconditioning. These organ-specific effects may be mediated through different molecular mechanisms or signal pathways such as peroxisome proliferator-activated receptor γ coactivator 1-α (PGC-1α), mitogen-activated protein kinase (MAPK) signaling, aryl hydrocarbon receptor (AhR)/nuclear factor-κB (NF-κB), nuclear factor erythroid 2-related factor 2 (Nrf2), heme oxygenase-1 (HO-1), Runt-related transcription factor 2 (RUNX2), bone morphogenic protein 2 (BMP2), osterix, Notch signaling, autophagy effectors, microRNAs, and reactive oxygen species induction. Anecdotal clinical studies also suggest that frailty may further accelerate renal function decline, thereby augmenting the accumulation of UTs in affected individuals. Judging from these threads of evidence, management strategies aiming for uremic toxin reduction may be a promising approach for frailty amelioration in patients with CKD. Uremic toxin lowering strategies may bear the potential of improving patients’ outcomes and restoring their quality of life, through frailty attenuation. Pathogenic molecule-targeted therapeutics potentially disconnect the association between uremic toxins and frailty, additionally serving as an outcome-modifying approach in the future." @default.
- W3166384713 created "2021-06-22" @default.
- W3166384713 creator A5016470107 @default.
- W3166384713 creator A5025625132 @default.
- W3166384713 date "2021-06-10" @default.
- W3166384713 modified "2023-09-30" @default.
- W3166384713 title "Uremic Toxins and Frailty in Patients with Chronic Kidney Disease: A Molecular Insight" @default.
- W3166384713 cites W1651661950 @default.
- W3166384713 cites W1824086090 @default.
- W3166384713 cites W1924777139 @default.
- W3166384713 cites W1967217398 @default.
- W3166384713 cites W1981477005 @default.
- W3166384713 cites W1989273717 @default.
- W3166384713 cites W1997093408 @default.
- W3166384713 cites W2005725527 @default.
- W3166384713 cites W2006379860 @default.
- W3166384713 cites W2007231956 @default.
- W3166384713 cites W2013494724 @default.
- W3166384713 cites W2024209230 @default.
- W3166384713 cites W2027358754 @default.
- W3166384713 cites W2029719641 @default.
- W3166384713 cites W2037721658 @default.
- W3166384713 cites W2044505412 @default.
- W3166384713 cites W2054664500 @default.
- W3166384713 cites W2062539813 @default.
- W3166384713 cites W2074597788 @default.
- W3166384713 cites W2079298382 @default.
- W3166384713 cites W2094678247 @default.
- W3166384713 cites W2112232517 @default.
- W3166384713 cites W2137597475 @default.
- W3166384713 cites W2145073188 @default.
- W3166384713 cites W2146226846 @default.
- W3166384713 cites W2160432066 @default.
- W3166384713 cites W2170660730 @default.
- W3166384713 cites W2177939130 @default.
- W3166384713 cites W2297901344 @default.
- W3166384713 cites W2332425387 @default.
- W3166384713 cites W2500071065 @default.
- W3166384713 cites W2535533723 @default.
- W3166384713 cites W2560177215 @default.
- W3166384713 cites W2563335821 @default.
- W3166384713 cites W2578922408 @default.
- W3166384713 cites W2615964728 @default.
- W3166384713 cites W2622468178 @default.
- W3166384713 cites W2625298560 @default.
- W3166384713 cites W2669563612 @default.
- W3166384713 cites W2734506013 @default.
- W3166384713 cites W2751697980 @default.
- W3166384713 cites W2767958159 @default.
- W3166384713 cites W2771711630 @default.
- W3166384713 cites W2777538610 @default.
- W3166384713 cites W2793071710 @default.
- W3166384713 cites W2795769491 @default.
- W3166384713 cites W2806565977 @default.
- W3166384713 cites W2875706432 @default.
- W3166384713 cites W2883939750 @default.
- W3166384713 cites W2892396086 @default.
- W3166384713 cites W2895231437 @default.
- W3166384713 cites W2899233889 @default.
- W3166384713 cites W2911724853 @default.
- W3166384713 cites W2914437754 @default.
- W3166384713 cites W2914578582 @default.
- W3166384713 cites W2917220094 @default.
- W3166384713 cites W2918920940 @default.
- W3166384713 cites W2920283819 @default.
- W3166384713 cites W2921572103 @default.
- W3166384713 cites W2943964171 @default.
- W3166384713 cites W2947670524 @default.
- W3166384713 cites W2950937096 @default.
- W3166384713 cites W2955868116 @default.
- W3166384713 cites W2960158858 @default.
- W3166384713 cites W2969755701 @default.
- W3166384713 cites W2971323837 @default.
- W3166384713 cites W2972869830 @default.
- W3166384713 cites W2978166531 @default.
- W3166384713 cites W2981828250 @default.
- W3166384713 cites W2987842868 @default.
- W3166384713 cites W2988011813 @default.
- W3166384713 cites W2991160674 @default.
- W3166384713 cites W3004337908 @default.
- W3166384713 cites W3006719160 @default.
- W3166384713 cites W3007626596 @default.
- W3166384713 cites W3008586925 @default.
- W3166384713 cites W3015068556 @default.
- W3166384713 cites W3015781934 @default.
- W3166384713 cites W3034400121 @default.
- W3166384713 cites W3034602289 @default.
- W3166384713 cites W3034872748 @default.
- W3166384713 cites W3048654474 @default.
- W3166384713 cites W3082122991 @default.
- W3166384713 cites W3082378435 @default.
- W3166384713 cites W3085274339 @default.
- W3166384713 cites W3085881798 @default.
- W3166384713 cites W3087396503 @default.
- W3166384713 cites W3088426205 @default.
- W3166384713 cites W3091837048 @default.
- W3166384713 cites W3091963223 @default.
- W3166384713 cites W3092306376 @default.